Andrew Guggenhime, Vaxcyte’s president and CFO, forfeited 7,155 shares at $60.36 per share, leaving him with 95,316 shares. The transaction represented about 7.0% of his prior Vaxcyte holding and carried code F, which denotes tax-related withholding, giving investors the reported ownership change and transaction classification.

Key Highlights

  • The filing assigns transaction code F to the share forfeiture.
  • Andrew Guggenhime owned 95,316 Vaxcyte shares after the transaction.
  • The forfeited shares represented about 7.0% of his prior holding.

Vaxcyte, Inc. (NASDAQ: PCVX) Chief Financial Officer Andrew Guggenhime forfeited 7,155 shares. Guggenhime also serves as Vaxcyte’s president.

$60.36 Share Forfeiture Recorded

The transaction was dated September 8, 2026, and assigned a per-share value of $60.36. The filing assigns transaction code F to the forfeiture. The filing identifies Guggenhime as Vaxcyte’s president and CFO and reports the share forfeiture.

Post-Transaction Ownership

Guggenhime owned 95,316 Vaxcyte shares after the forfeiture. The transaction represented about 7.0% of his prior shareholding. That percentage measures the forfeited shares against Guggenhime’s own earlier Vaxcyte position, while the 95,316 figure represents his stated ownership after the event.